Cover Image

A multicenter phase IV study to investigate the immunogenicity of recombinant human follicle-stimulating hormone and its impact on clinical outcomes in females undergoing controlled ovarian stimulation

Context: Therapeutic proteins can cause immune responses, which may have clinical implications. Aims: The aim of the study was to assess the immunogenicity of recombinant human follicle-stimulating hormone (r-hFSH), when used for controlled ovarian stimulation (COS). Settings and Design: Prospective...

Full description

Saved in:

Bibliographic Details
Main Authors:	Abha Majumdar (Author), Le Hoang (Author), Ly T Loc (Author), Padma Srivastava (Author), Chitra Ramamurthy (Author), Ratnabali Chakravorty (Author), Yogeshwar S Nandanwar (Author), M D Rashmi (Author), Rahul V Mayekar (Author), Jayashree Sridhar (Author), Ganesh H Divekar (Author), James John (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A multicenter, randomized, equivalence trial of a new recombinant human chorionic gonadotropin preparation versus ovitrelle® for ovulation in women undergoing intrauterine insemination following ovarian stimulation
by: Abha Majumdar, et al.
Published: (2019)

The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles
by: Chunxia Yang, et al.
Published: (2022)

Follicle-Stimulating Hormone: Fertility and Beyond
Published: (2019)

The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections - a pharmacokinetic study
by: Kuo Hsin-Chih, et al.
Published: (2009)

Reliability of follicle-stimulating hormone measurements in serum
by: Kaaks Rudolf, et al.
Published: (2003)

Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness Analysis
by: Li H, et al.
Published: (2024)

Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women
by: Marleen Nahuis, et al.
Published: (2009)

Associations of reproductive factors with postmenopausal follicle stimulating hormone
by: Rebecca Costa, et al.
Published: (2022)

Luteinizing hormone and follicle stimulating hormone synergy: A review of role in controlled ovarian hyper-stimulation
by: Gottumukkala Achyuta Rama Raju, et al.
Published: (2013)

Impact of gonadotropin-releasing hormone antagonist addition on pregnancy rates in gonadotropin-stimulated intrauterine insemination cycles
by: Shikha Jain, et al.
Published: (2016)

Increased Progesterone/Estradiol Ratio on the Day of hCG Administration Adversely Affects Success of In Vitro Fertilization-Embryo Transfer in Patients Stimulated with Gonadotropin-releasing Hormone Agonist and Recombinant Follicle-stimulating Hormone
by: Yu-Che Ou, et al.
Published: (2008)

Characterization of Constitutively Activating Eel Follicle-Stimulating Hormone Receptor
by: Jeong-Soo Kim, et al.
Published: (2019)

Clomiphene based ovarian stimulation in a commercial donor program
by: Shruti Gupta, et al.
Published: (2015)

Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women
by: Lammerich A, et al.
Published: (2015)

Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction
by: Munawar Hussain, et al.
Published: (2013)

Human Menopausal Gonadotropins in Combination for Stimulation does not Improve IVF Outcomes in POSEIDON Group 4 Patients, When Compared to Recombinant Follicle Stimulating Hormone Alone: A Prospective Randomized, Non-Blinded, Controlled Pilot Trial
by: Jiahui Qiu, et al.
Published: (2023)

Purification Process of a Recombinant Human Follicle Stimulating Hormone Biosimilar (Primapur<sup>®</sup>) to Yield a Pharmaceutical Product with High Batch-to-Batch Consistency
by: Maria Sinegubova, et al.
Published: (2022)

Poor second ovarian stimulation in cynomolgus monkeys (Macaca fascicularis) is associated with the production of antibodies against human follicle-stimulating hormone
by: Yasunari SEITA, et al.
Published: (2019)

Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?
by: M. Kirshenbaum, et al.
Published: (2021)

Follicle-stimulating hormone (FSH) promotes retinol uptake and metabolism in the mouse ovary
by: Zhuo Liu, et al.
Published: (2018)

Overriding follicle selection in controlled ovarian stimulation protocols: Quality vs quantity
by: Zelinski-Wooten Mary B, et al.
Published: (2004)

Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders
by: Qiuju Chen, et al.
Published: (2017)

Appropriate cut-off value for follicle-stimulating hormone in azoospermia to predict spermatogenesis
by: Chen Shyh-Chyan, et al.
Published: (2010)

Laparoscopic ovarian drilling reduces testosterone and luteinizing hormone/follicle-stimulating hormone ratio and improves clinical outcome in women with polycystic ovary syndrome
by: Priyanka Sinha, et al.
Published: (2019)

Profile of follitropin alpha/lutropin alpha combination for the stimulation of follicular development in women with severe luteinizing hormone and follicle-stimulating hormone deficiency
by: Rinaldi L, et al.
Published: (2016)

Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer-High Responder (MEGASET-HR) trial
by: Jared C. Robins, M.D, et al.
Published: (2020)

The Clinical Efficacy of Three Different Follicle-Stimulating Hormones for Follicle Growth and Development in Long-Protocol Controlled Ovarian Hyperstimulation Treatment
by: Zhang XQ, et al.
Published: (2021)

Recombinant FSH versus hMG in Controlled Ovarian Stimulation for IVF
by: Agus Supriyadi, et al.
Published: (2021)

Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden
by: Wex J, et al.
Published: (2013)

Follicle-stimulating hormone signaling in Sertoli cells: a licence to the early stages of spermatogenesis
by: Jia-Ming Wang, et al.
Published: (2022)

Differential regulation of follicle stimulating hormone by activin A and TGFB1 in murine gonadotropes
by: Miller William L, et al.
Published: (2005)

The frequency of follicle stimulating hormone receptor gene polymorphisms in Iranian infertile men with azoospermia
by: Behrouz Gharesi-Fard, et al.
Published: (2015)

Association of follicle stimulating hormone receptor promoter with ovarian response in IVF-ET patients
by: Wang Dan, et al.
Published: (2015)

Relationships between the antral follicle count, steroidogenesis, and secretion of follicle-stimulating hormone and anti-Müllerian hormone during follicular growth in cattle
by: Kenichiro Sakaguchi, et al.
Published: (2019)

Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis
by: Grassi Giuseppina, et al.
Published: (2006)

Anti-mullerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization
by: Ruma Satwik, et al.
Published: (2012)

Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility
by: Weghofer Andrea, et al.
Published: (2010)

Effects of anti-Müllerian hormone and follicle stimulating hormone levels on in vitro fertilization pregnancy rate
by: Yi-Pin Chen, et al.
Published: (2014)

Pharmacological Programming of Endosomal Signaling Activated by Small Molecule Ligands of the Follicle Stimulating Hormone Receptor
by: Silvia Sposini, et al.
Published: (2020)

Continuous follicle-stimulating hormone exposure from pituitary adenoma causes periodic follicle recruitment and atresia, which mimics ovarian hyperstimulation syndrome
by: Morishita M, et al.
Published: (2012)